Expert profile

Dr. Thomas Dayspring

Clinical lipidologist

Lipids • cholesterol and cardiovascular risk

1Discussion
109 minAnalysed
Last reviewed: Jul 23, 2026·Credential: MD, FACP; clinical lipidologist·First indexed: Jul 23, 2026

Related Health Areas

Topics discussed

About the expert

Focus: Lipids, ApoB, Cardiovascular risk

A clinical lipidologist widely known for teaching how cholesterol and lipoproteins drive heart disease. He focuses on particle-based measures such as ApoB rather than standard cholesterol numbers. His views align with mainstream cardiology and prevention guidelines.

Expert discussions with Dr. Thomas Dayspring

Lowering ApoB and cholesterol: which therapies cut heart risk
Heart disease from narrowing arteries usually builds up gradually over decades, as cholesterol-carrying particles lodge in the artery wall and form fatty plaques. A blood marker called ApoB counts these particles directly, and it can flag risk a standard cholesterol test misses. Several proven medicines lower these particles in different ways. This discussion covers how they work, how well they prevent heart attacks and strokes, and why starting earlier may matter.